1.99
0.02 (1.02%)
0.02 (1.02%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02 | 1.02% | 1.99 | 10:02:42 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 1.95 | 2.0245 | 1.95 | 1.97 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.97 | 2.00 | 0.03 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27 | 16,505 | $ 2.01 | $ 33,184 | 186,006 | 0.50 - 5.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:05:37 | 2 | $ 1.9889 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 25.64M | 13.02M | 6.48M | $ 1.11M | $ - | -0.23 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.98 | 2.1046 | 1.8544 | 1.99 | 78,044 | 0.01 | 0.51% |
| 1 Month | 1.77 | 2.38 | 1.62 | 2.12 | 188,242 | 0.22 | 12.43% |
| 3 Months | 2.26 | 3.65 | 1.62 | 2.77 | 445,436 | -0.27 | -11.95% |
| 6 Months | 1.61 | 4.69 | 1.27 | 3.42 | 811,812 | 0.38 | 23.6% |
| 1 Year | 1.02 | 5.10 | 0.50 | 3.33 | 672,982 | 0.97 | 95.1% |
| 3 Years | 3.50 | 5.10 | 0.50 | 3.29 | 241,740 | -1.51 | -43.14% |
| 5 Years | 4.39 | 5.55 | 0.50 | 3.60 | 227,053 | -2.40 | -54.67% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
